Incannex Healthcare IXHL
NASDAQ IXHL
$3.21 -0.04 (-1.23%)
At close: Oct 2, 2026 · 4:00 PM EDT

Incannex Healthcare (IXHL) Price to Sales (2025)

Updated

Incannex Healthcare's Price to Sales came in at 86.54 for fiscal Q4 2025 (quarter ended Jun 30, 2025).

Analysis

Incannex Healthcare (IXHL) Price to Sales (2025) Analysis & Trends

  • Going back by fiscal year, Price to Sales was 8595.18 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Incannex Healthcare 40.27 Mn 40.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 86.54
API Access

Incannex Healthcare Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=IXHL&period=max&api_key=YOUR_API_KEY